Ernesto Wasserman

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

Daniel D. Von Hoff, Joseph J. Stephenson, Peter J. Rosen et al. · Journal of Clinical Oncology · 2010 · 628 citations

Cancer Management, Oligonucleotide Microarray, Pathology +22

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

Reinhard Dummer, Dirk Schadendorf, Paolo A. Ascierto et al. · The Lancet Oncology · 2017 · 482 citations · Full text

Oncology, Binimetinib Versus Dacarbazine, Medicine +7

Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports

Ernesto Wasserman, Anne Myara, François Lokiec et al. · Annals of Oncology · 1997 · 213 citations

Medicine, Severe Cpt-11 Toxicity, Case Reports

Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With Pharmacokinetics

Ernesto Wasserman, C. Cuvier, François Lokiec et al. · Journal of Clinical Oncology · 1999 · 134 citations

Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer

Alison M. Schram, Kōichi Goto, Dong-Wan Kim et al. · New England Journal of Medicine · 2025 · 78 citations · Full text